These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 10525293)

  • 1. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
    Lurtz MM; Hareland ML; Pedersen SE
    Biochemistry; 1997 Feb; 36(8):2068-75. PubMed ID: 9047305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
    Sun H; McCardy EA; Machu TK; Blanton MP
    J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
    Amitai G; Herz JM; Bruckstein R; Luz-Chapman S
    Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinacrine noncompetitive inhibitor binding site localized on the Torpedo acetylcholine receptor in the open state.
    Johnson DA; Ayres S
    Biochemistry; 1996 May; 35(20):6330-6. PubMed ID: 8639577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
    Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
    Arias HR
    Mol Membr Biol; 1995; 12(4):339-47. PubMed ID: 8747279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cembranoid interaction with the nicotinic acetylcholine receptor.
    Hann RM; Pagán OR; Gregory L; Jácome T; Rodríguez AD; Ferchmin PA; Lu R; Eterović VA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):253-60. PubMed ID: 9765345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
    Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
    Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
    Weiland GA; Durkin JA; Henley JM; Simasko SM
    Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor.
    Arias HR; McCardy EA; Blanton MP
    Mol Pharmacol; 2001 May; 59(5):1051-60. PubMed ID: 11306687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosterically linked noncompetitive antagonist binding sites in the resting nicotinic acetylcholine receptor ion channel.
    Arias HR; McCardy EA; Bayer EZ; Gallagher MJ; Blanton MP
    Arch Biochem Biophys; 2002 Jul; 403(1):121-31. PubMed ID: 12061809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor.
    Andreeva IE; Nirthanan S; Cohen JB; Pedersen SE
    Biochemistry; 2006 Jan; 45(1):195-204. PubMed ID: 16388595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-selective photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor by azide derivatives of ethidium bromide.
    Pedersen SE
    Mol Pharmacol; 1995 Jan; 47(1):1-9. PubMed ID: 7838117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
    Valenzuela CF; Kerr JA; Duvvuri P; Johnson DA
    Mol Pharmacol; 1992 Feb; 41(2):331-6. PubMed ID: 1538711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
    Min CK; Owens J; Weiland GA
    Mol Pharmacol; 1994 Feb; 45(2):221-7. PubMed ID: 7509439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of lipids and ligands with nicotinic acetylcholine receptor vesicles assessed by electron paramagnetic resonance spectroscopy.
    Arias HR
    Methods Mol Biol; 2010; 606():291-318. PubMed ID: 20013404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1997 Jul; 1347(1):9-22. PubMed ID: 9233683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.